RadNet
RDNTNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $77.94 Prior regular-session close from the quote source.
- $77.83–$79.96 Regular-session low and high so far today.
- 732.3K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $50.82–$85.84 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own RDNT if its outpatient imaging scale keeps attracting patients, payors and referring physicians while management turns that volume into cash rather than merely larger, capital-intensive revenue.
RDNT price history
Loading recent earnings…
Investment thesis
What must happen next
Outpatient imaging demand and Rad net’s national scale continue to route patients and referrals into its centers rather than hospital imaging departments or smaller independents.StrengtheningMateriality: High
RadNet describes itself in Item 1 as a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. If this holds, Rad net can keep filling high fixed-cost imaging assets; if it breaks, revenue growth and operating leverage both weaken.
Watch: Large hospital systems or health-system joint ventures in RadNet’s core markets redirect physician referrals back into owned imaging assets.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
RadNet describes itself in Item 1 as a leading national provider of diagnostic imaging services in the United States based.
Open source ↗Rad net’s local density, utilization management and payer contracting must let incremental scan volume cover radiologist labor, rent, equipment, acquisition and integration costs.HoldingMateriality: High
GAAP annual operating income remained positive at $62.0 million in FY2025. This is the difference between a valuable scaled platform and a low-margin roll-up that grows but does not compound owner earnings.
Watch: Radiologist shortages or wage inflation force RadNet to pay up for clinical capacity faster than reimbursement or volume can offset.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income remained positive at $62.0 million in FY2025.
Open source ↗The imaging-center model continues to convert recurring scan volume and payer collections into operating cash that can fund equipment, acquisitions and Digital Health investment without relying primarily on dilution or incremental leverage.StrengtheningMateriality: Medium
GAAP annual operating cash flow increased from $146.4 million in FY2022 to $298.8 million in FY2025. If cash conversion holds, Rad net has strategic flexibility; if it breaks, growth may destroy per-share value through debt, equity issuance or underinvestment.
Watch: Receivables collection slows because payors delay payment, increase denials or intensify prior authorization requirements.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow increased from $146.4 million in FY2022 to $298.8 million in FY2025.
Open source ↗Rad net’s liquidity gives management room to consolidate imaging assets and invest in technology, but value creation depends on disciplined capital allocation rather than simply buying more revenue.StrengtheningMateriality: Medium
Cash and cash equivalents were $767.2 million at FY2025 year-end. A strong cash position can accelerate growth, but overpaying for centers or software would transfer value away from shareholders.
Watch: Management pursues a large acquisition at a price that assumes reimbursement and labor conditions improve materially.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash and cash equivalents were $767.2 million at FY2025 year-end.
Open source ↗Digital Health must become a practical productivity and clinical-differentiation tool inside Rad net’s imaging network, not a separate cost center whose promise masks weak center economics.HoldingMateriality: Medium
RadNet identifies a divisional chief executive for Digital Health, indicating a dedicated operating focus. If Digital Health improves radiologist throughput, detection quality or payor/provider relationships, Rad net deserves a better growth profile; if not, it can pressure earnings and valuation.
Watch: Radiologists do not adopt RadNet’s AI tools because workflow integration is poor or clinical false-positive rates are unacceptable.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
RadNet identifies a divisional chief executive for Digital Health, indicating a dedicated operating focus.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Outpatient imaging demand and Rad net’s national scale continue to route patients and referrals into its centers rather than hospital imaging departments or smaller independents. If this holds, Rad net can keep filling high fixed-cost imaging assets; if it breaks, revenue growth and operating leverage both weaken.
Rad net’s local density, utilization management and payer contracting must let incremental scan volume cover radiologist labor, rent, equipment, acquisition and integration costs. This is the difference between a valuable scaled platform and a low-margin roll-up that grows but does not compound owner earnings.
The imaging-center model continues to convert recurring scan volume and payer collections into operating cash that can fund equipment, acquisitions and Digital Health investment without relying primarily on dilution or incremental leverage. If cash conversion holds, Rad net has strategic flexibility; if it breaks, growth may destroy per-share value through debt, equity issuance or underinvestment.
Rad net’s liquidity gives management room to consolidate imaging assets and invest in technology, but value creation depends on disciplined capital allocation rather than simply buying more revenue. A strong cash position can accelerate growth, but overpaying for centers or software would transfer value away from shareholders.
Digital Health must become a practical productivity and clinical-differentiation tool inside Rad net’s imaging network, not a separate cost center whose promise masks weak center economics. If Digital Health improves radiologist throughput, detection quality or payor/provider relationships, Rad net deserves a better growth profile; if not, it can pressure earnings and valuation.
All standing thesis claims
Original report summary
its outpatient imaging scale keeps attracting patients, payors and referring physicians while management turns that volume into cash rather than merely larger, capital-intensive revenue.
Bull case and bear case
Bull case and bear case for RadNet
Where the evidence on RadNet stands: Holding on the latest evidence (Nov 12, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.
Bull case: what the evidence supports
Outpatient imaging demand and Rad net’s national scale continue to route patients and referrals into its centers rather than hospital imaging departments or smaller independents.
Rad net’s local density, utilization management and payer contracting must let incremental scan volume cover radiologist labor, rent, equipment, acquisition and integration costs.
The imaging-center model continues to convert recurring scan volume and payer collections into operating cash that can fund equipment, acquisitions and Digital Health investment without relying primarily on dilution or incremental leverage.
Rad net’s liquidity gives management room to consolidate imaging assets and invest in technology, but value creation depends on disciplined capital allocation rather than simply buying more revenue.
Digital Health must become a practical productivity and clinical-differentiation tool inside Rad net’s imaging network, not a separate cost center whose promise masks weak center economics.
Bear case: what would count against it
Large hospital systems or health-system joint ventures in RadNet’s core markets redirect physician referrals back into owned imaging assets.
Radiologist shortages or wage inflation force RadNet to pay up for clinical capacity faster than reimbursement or volume can offset.
Receivables collection slows because payors delay payment, increase denials or intensify prior authorization requirements.
Thesis-Break Engine
Thesis-break watch · RadNet
Loading the break-condition record for RadNet.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
RadNet filed an SEC 8-K on 2026-11-09: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
RadNet filed an SEC 8-K on 2026-10-26: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedOther material event.
RadNet filed an SEC 8-K on 2026-08-14: Other material event. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Large hospital systems or health-system joint ventures in RadNet’s core markets redirect physician referrals back into owned imaging assets.
- Radiologist shortages or wage inflation force RadNet to pay up for clinical capacity faster than reimbursement or volume can offset.
- Receivables collection slows because payors delay payment, increase denials or intensify prior authorization requirements.
- Management pursues a large acquisition at a price that assumes reimbursement and labor conditions improve materially.
- Radiologists do not adopt RadNet’s AI tools because workflow integration is poor or clinical false-positive rates are unacceptable.
RDNT news
Loading headlines…
Financial statements
RDNT income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
RDNT: quick answers
- Which well-known investors own RDNT?
- 1 of the 37 well-known funds tracked here reported RDNT shares in their latest 13F filing. By share of the fund's portfolio: Soros Fund Management (George Soros), 0.1%. Fund portfolios
RDNT in well-known investors’ portfolios
1 of 37 funds reported RDNT shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| George SorosSoros Fund Management | 0.09% | $7.2M | −73.4% | Q2 2026 |
